Latest return on equity
Travere Therapeutics Return on equity
Direct answer
Travere Therapeutics's return on equity is -236.36%.
The verified market snapshot reports -236.36%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 30, 2026.
Get free Travere Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -236.36%
Explore related company data
View Travere Therapeutics's market capitalizationView Travere Therapeutics's price-to-book ratioView Travere Therapeutics's 52-week price rangeView Travere Therapeutics's revenue growthView Travere Therapeutics's profit marginView Travere Therapeutics's debt-to-equity ratioView all Travere Therapeutics key metricsReturn to Travere Therapeutics profile